Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.4B |
| 2 |
ExxonMobil
XOM
|
+$1.39B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$932M |
| 4 |
Procter & Gamble
PG
|
+$925M |
| 5 |
Walmart Inc
WMT
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$1.66B |
| 2 |
Salesforce
CRM
|
+$1.17B |
| 3 |
Lam Research
LRCX
|
+$974M |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$972M |
| 5 |
Applied Materials
AMAT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.72% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 10.07% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Trinity Industries
TRN
$2.38B
| $6.22M | ﹤0.01% |
223,339
-229
| -0.1% | -$5.9K |
|
477
AbbVie
ABBV
$435B
| $6.18M | ﹤0.01% |
33,923
+14
| +0% | +$2.41K |
|
478
Donnelley Financial Solutions
DFIN
$1.16B
| $6.17M | ﹤0.01% |
99,426
-2,697
| -3% | -$169K |
|
479
Morningstar
MORN
$7.53B
| $6.17M | ﹤0.01% |
19,993
-2,962
| -13% | -$853K |
|
480
Silicon Laboratories
SLAB
$7.23B
| $6.14M | ﹤0.01% |
42,689
+5,450
| +15% | +$722K |
|
481
Power Integrations
POWI
$3.61B
| $5.98M | ﹤0.01% |
83,522
+13,228
| +19% | +$988K |
|
|
SIX
482
DELISTED
Six Flags Entertainment Corp.
SIX
| $5.94M | ﹤0.01% |
225,791
+16,919
| +8% | +$425K |
|
483
Devon Energy
DVN
$47.3B
| $5.87M | ﹤0.01% |
117,041
-10,045
| -8% | -$446K |
|
484
Worthington Enterprises
WOR
$2.86B
| $5.85M | ﹤0.01% |
93,999
+6,813
| +8% | +$406K |
|
485
PTC
PTC
$16B
| $5.81M | ﹤0.01% |
30,761
+6,704
| +28% | +$1.21M |
|
486
Alkermes
ALKS
$8.25B
| $5.78M | ﹤0.01% |
213,437
+153,495
| +256% | +$4.36M |
|
487
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $5.76M | ﹤0.01% |
137,803
-8,891
| -6% | -$363K |
|
488
Advanced Drainage Systems
WMS
$10.9B
| $5.75M | ﹤0.01% |
33,402
+4,554
| +16% | +$686K |
|
489
Federal Realty Investment Trust
FRT
$10.3B
| $5.73M | ﹤0.01% |
56,073
-177
| -0.3% | -$17.9K |
|
490
Hexcel
HXL
$7.82B
| $5.71M | ﹤0.01% |
78,442
-5,194
| -6% | -$374K |
|
491
F5
FFIV
$22.7B
| $5.71M | ﹤0.01% |
30,137
+2,069
| +7% | +$382K |
|
492
Cooper Companies
COO
$14.5B
| $5.69M | ﹤0.01% |
56,057
+4,905
| +10% | +$475K |
|
493
CVS Health
CVS
$122B
| $5.67M | ﹤0.01% |
71,100
+3,240
| +5% | +$247K |
|
494
iShares MSCI Taiwan ETF
EWT
$10.7B
| $5.65M | ﹤0.01% |
116,061
-3,333
| -3% | -$154K |
|
495
Upbound Group
UPBD
$1.16B
| $5.65M | ﹤0.01% |
160,346
+9,284
| +6% | +$310K |
|
496
Regeneron Pharmaceuticals
REGN
$80.8B
| $5.6M | ﹤0.01% |
5,814
+192
| +3% | +$183K |
|
497
Vanguard Total Bond Market
BND
$158B
| $5.48M | ﹤0.01% |
75,450
+2,176
| +3% | +$158K |
|
498
Uber
UBER
$153B
| $5.39M | ﹤0.01% |
70,052
-24,441
| -26% | -$1.75M |
|
499
Globant
GLOB
$1.61B
| $5.36M | ﹤0.01% |
26,536
+9
| +0% | +$2.02K |
|
500
ICU Medical
ICUI
$4.61B
| $5.26M | ﹤0.01% |
49,000
-32
| -0.1% | -$3.18K |
|
Similar funds
Ken Fisher's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Fisher held 1,068 positions worth $214B, up 13% from $189B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2024 filing shows 87 new, 392 increased, 448 reduced and 104 closed positions. Its largest new stake was Nomura Holdings: 8,478,338 shares worth $54.4M. The largest sale was ASML, an estimated $1.66B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q1 2024 buy was Nomura Holdings: 8,478,338 shares worth $54.4M.
- Ken Fisher added most to Chevron in Q1 2024, an estimated $1.4B increase.
- Ken Fisher's biggest Q1 2024 reduction was ASML, cutting an estimated $1.66B.
- Ken Fisher fully exited Veradigm Inc. Common Stock in Q1 2024, selling an estimated $23.8M.
- Ken Fisher's ten largest holdings make up 31% of its $214B portfolio in Q1 2024.
- Ken Fisher opened 87 new positions and closed 104 in Q1 2024.
- Ken Fisher's portfolio value rose 13% quarter-over-quarter to $214B.
Based on Fisher Asset Management's 13F filing for Q1 2024, filed 9 May 2024.